Cost-Effectiveness of Adjuvanted Quadrivalent Influenza Vaccine for Adults over 65 in France.
Marc PaccalinGaëtan GavazziQuentin BerkovitchHenri LeleuRomain MoreauEmanuele CigliaNansa BurletJoaquin F Mould-QuevedoPublished in: Vaccines (2024)
This study highlights the cost-effectiveness of aQIV versus SD-QIV and HD-QIV, preventing influenza cases, hospitalizations, and deaths.
Keyphrases